National Comprehensive Cancer Network



About NCCN

Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenström's Macroglobulinemia Panel - Disclosures as of 5/25/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Melissa Alsina, MD

None

Onyx Pharmaceuticals, Inc.

None

None

4/10/2013

Kenneth C. Anderson, MD

None

Celgene Corporation;
Onyx Pharmaceuticals, Inc.;
Gilead Sciences;
sanofi-aventis U.S.

acetylon;
oncopep

acetylon;
oncopep

2/21/2013

William Bensinger, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Pharmacyclics

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

4/5/2013

J. Sybil Biermann, MD

None

None

None

None

12/9/2012

Jason C. Chandler, MD

None

Onyx Pharmaceuticals, Inc.

None

None

2/26/2013

Caitlin Costello, MD

None

None

None

None

5/20/2013

Steven Devine, MD

Genzyme Corporation

GlaxoSmithKline

None

None

5/14/2013

Benjamin Djulbegovic, MD, PhD

None

None

None

None

3/27/2013

Edward A. Faber, Jr., DO, MS

None

sanofi-aventis U.S.

None

None

4/2/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Cristina Gasparetto, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

5/22/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Francisco Hernandez-Ilizaliturri, MD

None

Amgen Inc.;
Celgene Corporation

None

None

8/30/2012

Carol Ann Huff, MD

Geron;
Pharmacyclics

Celgene Corporation;
Novartis Pharmaceuticals Corporation;
sanofi-aventis U.S.

None

None

5/14/2013

Adetola Kassim, MD, MS

None

None

None

None

4/4/2013

Amrita Y. Krishnan, MD, FACP

Celgene Corporation;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.

Celgene Corporation;
Genentech, Inc.;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.

Celgene Corporation;
Onyx Pharmaceuticals, Inc.;
Pharmacyclics

None

8/16/2012

Rashmi Kumar, PhD

None

None

None

None

2/15/2012

Michaela Liedtke, MD

None

None

None

None

4/12/2013

Joan S. McClure, MS

None

None

None

None

7/23/2012

Ruby Meredith, MD, PhD

None

None

None

None

4/5/2013

Noopur Raje, MD

Amgen Inc.;
Eli Lilly and Company;
Acetylon

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

8/15/2012

Dorothy Shead, MS

None

None

None

None

8/3/2012

Seema Singhal, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

5/20/2013

George Somlo, MD

AstraZeneca Pharmaceuticals LP;
Celgene Corporation;
Genentech, Inc.;
National Cancer Institute;
Veridex, LLC

Celgene Corporation;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Abraxane;
Roche Laboratories, Inc.

None

None

8/16/2012

Keith Stockerl-Goldstein, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

5/23/2013

Steven P. Treon, MD, PhD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

None

10/23/2012

Donna M. Weber, MD

Celgene Corporation;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
Ortho Biotech Products, L.P.

Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
proteolix

None

None

4/14/2010

Joachim Yahalom, MD

None

None

None

None

2/8/2012

Maurizio Zangari, MD

        

Pending

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved